Last reviewed 2026-04-22 · How we verify

Placebo for "Deficiency of Qi and Yang"

The University of Hong Kong · FDA-approved active Small molecule

Placebo for "Deficiency of Qi and Yang" is a Small molecule drug developed by The University of Hong Kong. It is currently FDA-approved for Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis).

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect. Used for Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis).

At a glance

Generic name	Placebo for "Deficiency of Qi and Yang"
Sponsor	The University of Hong Kong
Modality	Small molecule
Therapeutic area	Traditional Chinese Medicine / Placebo Control
Phase	FDA-approved

Mechanism of action

Placebos are inert substances used as controls in clinical trials or therapeutic contexts. Any observed clinical benefit derives from patient expectation, the therapeutic ritual, and psychobiological mechanisms rather than direct molecular action. In traditional medicine frameworks like Traditional Chinese Medicine, a placebo for 'Deficiency of Qi and Yang' would have no measurable biochemical activity.

Approved indications

Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis)

Common side effects

No common side effects on file.

Key clinical trials

Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Placebo for "Deficiency of Qi and Yang" CI brief — competitive landscape report
Placebo for "Deficiency of Qi and Yang" updates RSS · CI watch RSS
The University of Hong Kong portfolio CI

Frequently asked questions about Placebo for "Deficiency of Qi and Yang"

What is Placebo for "Deficiency of Qi and Yang"?

Placebo for "Deficiency of Qi and Yang" is a Small molecule drug developed by The University of Hong Kong, indicated for Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis).

How does Placebo for "Deficiency of Qi and Yang" work?

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.

What is Placebo for "Deficiency of Qi and Yang" used for?

Placebo for "Deficiency of Qi and Yang" is indicated for Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis).

Who makes Placebo for "Deficiency of Qi and Yang"?

Placebo for "Deficiency of Qi and Yang" is developed and marketed by The University of Hong Kong (see full The University of Hong Kong pipeline at /company/the-university-of-hong-kong).

What development phase is Placebo for "Deficiency of Qi and Yang" in?

Placebo for "Deficiency of Qi and Yang" is FDA-approved (marketed).

Manufacturer: The University of Hong Kong — full pipeline
Therapeutic area: All drugs in Traditional Chinese Medicine / Placebo Control
Indication: Drugs for Deficiency of Qi and Yang (Traditional Chinese Medicine diagnosis)
Compare: Placebo for "Deficiency of Qi and Yang" vs similar drugs
Pricing: Placebo for "Deficiency of Qi and Yang" cost, discount & access